Evangelia Psarrou

Hardworking and highly organized Imperial College MSc and BSc graduate with strong expertise in biological sciences and translational medicine. Experienced in advanced molecular and data analysis techniques, with a track record of working in state-of-the-art labs on stem cell and cardiac research. Skilled in project management, collaboration, and scientific communication, with certifications in drug discovery, commercialization, and project leadership.

Eager to apply both technical knowledge and transferable skills to innovative roles across the life sciences, healthcare, and pharmaceutical sectors. Currently working as a freelancer for Outlier AI.

Recent MSc graduate in Genes, Drugs & Stem Cells – Novel Therapies at Imperial College London, with hands-on research experience in cardiac physiology, stem-cell biology, and translational therapeutics. Skilled in experimental design, data analysis, and scientific writing, with additional experience drafting a full British Heart Foundation PhD studentship grant proposal in collaboration with Imperial’s National Heart & Lung Institute.

Currently contributing to Outlier AI as a freelance biomedical data annotator, applying domain expertise to ensure the accuracy and consistency of AI-driven scientific datasets. Experienced in multidisciplinary collaboration, precision data work, and managing multiple projects alongside part-time professional roles.

Combines a strong scientific foundation with analytical thinking, technical literacy, and a proactive approach to research and innovation — seeking to apply these skills within a graduate-level research, consulting, or biotech environment.

Imperial College London — MSc Genes, Drugs and Stem Cells: Novel Therapies (2023–2024)

National Heart and Lung Institute, Imperial Center for Translational and Experimental Medicine

Graduated with Merit. This master’s program combined regenerative medicine, pharmacology, and gene therapy, with core modules including Regenerative Medicine, Advanced Topics in Regenerative Medicine, Gene & Nucleic Acid Therapies, and New Horizons in Pharmacology. My research project focused on the development and characterization of stem-cell-derived cardiomyocytes (iPSC-CMs) for cardiac regeneration therapy and drug development, assessing functional maturation (force production, beating rate, and response to pacing) and studying their integration with human living myocardial slices (LMS).